125 related articles for article (PubMed ID: 14529830)
1. Macrophage apolipoprotein A-I expression protects against atherosclerosis in ApoE-deficient mice and up-regulates ABC transporters.
Su YR; Ishiguro H; Major AS; Dove DE; Zhang W; Hasty AH; Babaev VR; Linton MF; Fazio S
Mol Ther; 2003 Oct; 8(4):576-83. PubMed ID: 14529830
[TBL] [Abstract][Full Text] [Related]
2. Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo.
Ishiguro H; Yoshida H; Major AS; Zhu T; Babaev VR; Linton MF; Fazio S
J Biol Chem; 2001 Sep; 276(39):36742-8. PubMed ID: 11477092
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF
Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413
[TBL] [Abstract][Full Text] [Related]
4. Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression.
Thorngate FE; Yancey PG; Kellner-Weibel G; Rudel LL; Rothblat GH; Williams DL
J Lipid Res; 2003 Dec; 44(12):2331-8. PubMed ID: 12951361
[TBL] [Abstract][Full Text] [Related]
5. Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1.
Su YR; Dove DE; Major AS; Hasty AH; Boone B; Linton MF; Fazio S
Circulation; 2005 May; 111(18):2373-81. PubMed ID: 15851589
[TBL] [Abstract][Full Text] [Related]
6. Increased ABCA1 activity protects against atherosclerosis.
Singaraja RR; Fievet C; Castro G; James ER; Hennuyer N; Clee SM; Bissada N; Choy JC; Fruchart JC; McManus BM; Staels B; Hayden MR
J Clin Invest; 2002 Jul; 110(1):35-42. PubMed ID: 12093886
[TBL] [Abstract][Full Text] [Related]
7. Influence of macrophage-derived apolipoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apolipoprotein E-deficient mice.
Spangenberg J; Curtiss LK
Biochim Biophys Acta; 1997 Nov; 1349(2):109-21. PubMed ID: 9421184
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice.
Horie T; Baba O; Kuwabara Y; Chujo Y; Watanabe S; Kinoshita M; Horiguchi M; Nakamura T; Chonabayashi K; Hishizawa M; Hasegawa K; Kume N; Yokode M; Kita T; Kimura T; Ono K
J Am Heart Assoc; 2012 Dec; 1(6):e003376. PubMed ID: 23316322
[TBL] [Abstract][Full Text] [Related]
9. Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1-/- bone marrow.
Ranalletta M; Wang N; Han S; Yvan-Charvet L; Welch C; Tall AR
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2308-15. PubMed ID: 16917103
[TBL] [Abstract][Full Text] [Related]
10. ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages.
Boisvert WA; Black AS; Curtiss LK
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):525-30. PubMed ID: 10073953
[TBL] [Abstract][Full Text] [Related]
11. Independent protective roles for macrophage Abcg1 and Apoe in the atherosclerotic lesion development.
Lammers B; Out R; Hildebrand RB; Quinn CM; Williamson D; Hoekstra M; Meurs I; Van Berkel TJ; Jessup W; Van Eck M
Atherosclerosis; 2009 Aug; 205(2):420-6. PubMed ID: 19217108
[TBL] [Abstract][Full Text] [Related]
12. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
[TBL] [Abstract][Full Text] [Related]
14. Increased atherosclerosis in P2Y13/apolipoprotein E double-knockout mice: contribution of P2Y13 to reverse cholesterol transport.
Lichtenstein L; Serhan N; Espinosa-Delgado S; Fabre A; Annema W; Tietge UJ; Robaye B; Boeynaems JM; Laffargue M; Perret B; Martinez LO
Cardiovasc Res; 2015 May; 106(2):314-23. PubMed ID: 25770145
[TBL] [Abstract][Full Text] [Related]
15. Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer.
Zannis VI; Chroni A; Kypreos KE; Kan HY; Cesar TB; Zanni EE; Kardassis D
Curr Opin Lipidol; 2004 Apr; 15(2):151-66. PubMed ID: 15017358
[TBL] [Abstract][Full Text] [Related]
16. Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.
Hewing B; Parathath S; Barrett T; Chung WK; Astudillo YM; Hamada T; Ramkhelawon B; Tallant TC; Yusufishaq MS; Didonato JA; Huang Y; Buffa J; Berisha SZ; Smith JD; Hazen SL; Fisher EA
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):779-89. PubMed ID: 24407029
[TBL] [Abstract][Full Text] [Related]
17. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages.
Aiello RJ; Brees D; Bourassa PA; Royer L; Lindsey S; Coskran T; Haghpassand M; Francone OL
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):630-7. PubMed ID: 11950702
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis.
Van Eck M; Herijgers N; Yates J; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3117-26. PubMed ID: 9409301
[TBL] [Abstract][Full Text] [Related]
19. Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow.
Baldán A; Pei L; Lee R; Tarr P; Tangirala RK; Weinstein MM; Frank J; Li AC; Tontonoz P; Edwards PA
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2301-7. PubMed ID: 16888235
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation shows superior atheroprotective effects of gene therapy with apolipoprotein A-I Milano compared with wild-type apolipoprotein A-I in hyperlipidemic mice.
Wang L; Sharifi BG; Pan T; Song L; Yukht A; Shah PK
J Am Coll Cardiol; 2006 Oct; 48(7):1459-68. PubMed ID: 17010811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]